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Abstract: Strawberries, a popularly consumed berry fruit, are rich in bioactive compounds with
antioxidant effects. In this study, we examined the effects of two dietary achievable doses of strawberries on the antioxidant status and biomarkers of endothelial function in adults with features of
metabolic syndrome and a confirmed low baseline of fruit and vegetable intake. In a 14-week randomized controlled crossover study, participants were assigned to one of three groups for four weeks
separated by a one-week washout period: control powder, one serving (low dose: 13 g strawberry
powder/day), or 2.5 servings (high dose: 32 g strawberry powder/day). Blood samples and health
data were collected at baseline and at the end of each four-week phase of intervention. Thirty-three
participants completed all three phases of the trial. Significant increases were observed in serum
antioxidant capacity and superoxide dismutase activity as well as decreases in lipid peroxidation
after both low and high dose strawberry phases when compared with the control phase. Significant
decreases were also observed in soluble vascular cell adhesion molecule-1 and tumor necrosis factorα with the high dose strawberry phase. These data confirm that consuming strawberries for four
weeks significantly improves antioxidant status, endothelial function, and inflammation in adults
with cardiometabolic risks.
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1. Introduction

published maps and institutional affil-

In recent years, accumulated evidence from several lines of research has supported the
benefits of dietary berries for improving cardiometabolic risk in the adult population [1–4].
Most of these benefits have been attributed to the role of berry phytochemicals, especially
the polyphenolic flavonoids and other bioactive compounds, towards minimizing oxidative stress, inflammation, and related pathological pathways underlying diabetes and
vascular dysfunction [5]. Oxidative stress has been positively correlated with endothelial
dysfunction [6,7], and biomarkers of endothelial dysfunction, such as adhesion and inflammation molecules, have been shown to be modulated by dietary polyphenols found in
plant-based diets [8]. While epidemiological studies show an inverse association of dietary
berry consumption with diabetes risk [1,2], randomized controlled trials on the effects of
berries on biomarkers of antioxidant/oxidative stress status and endothelial function are
lacking in adults with cardiometabolic risk factors.
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Antioxidant enzymes and their cofactors, such as the concentration of glutathione,
have been shown to be decreased in erythrocytes of patients with type 2 diabetes (T2D),
consistent with increased susceptibility to oxidative damage and other complications [9,10].
The enzymes of the glutathione system, such as glutathione reductase and glutathione
peroxidase, are also altered in diabetic vs. non-diabetic control subjects [11,12]. Among
the categories of dietary phytochemicals with known antioxidant effects in humans, anthocyanins and ellagic acid present in the berries have been shown to improve antioxidant enzyme profiles. In a clinical trial in healthy volunteers (n = 57), consumption of
anthocyanin-rich fruit juice caused a significant increase in superoxide dismutase (SOD)
activity when compared to the placebo group [13]. In another study among patients with
T2D (n = 44), ellagic acid supplementation significantly increased activities of SOD, as well
as glutathione peroxidase enzymes, and increased total blood antioxidant capacity vs. the
placebo group [14]. Anthocyanins and ellagic acid are the major bioactive compounds in
dietary berries, especially in strawberries [15], which justifies the opportunity to examine
their effects on these antioxidant biomarkers. While these results have been encouraging,
the small number of such reported trials, as well as the lack of such studies conducted in
adults with metabolic syndrome or prediabetes, makes it difficult to clarify the potential
role of berries and their bioactive compounds on antioxidant profiles in these adults at
risk. Endothelial dysfunction underlies the initiation and progression of atherosclerotic
cardiovascular disease [16]. Again, very few studies have examined the role of dietary
berries on biomarkers of endothelial dysfunction. In one clinical study among adults with
hypercholesterolemia (n = 150), administration of purified anthocyanins significantly decreased adhesion molecules and biomarkers of inflammation vs. placebo [17]. On the other
hand, in adults with cardiometabolic risk (n = 18), consumption of a wild blueberry drink
decreased DNA oxidative damage but did not affect biomarkers of endothelial function and
inflammation [18]. As conflicting results could arise from differences in sample size and
participants’ metabolic characteristics, there is a need to examine these effects in controlled
studies in adults with metabolic syndrome.
Among dietary berries, commonly consumed berries such as blueberries, cranberries,
and strawberries, have shown distinct benefits in adults with metabolic syndrome [19].
Our group has previously reported the effects of functional foods such as green tea, blueberries, and strawberries on improving antioxidant profiles and biomarkers of endothelial
function in adults with diabetes risk [20–22]. We recently reported a dose–response study
in which we observed improved insulin resistance following intake of a dietary achievable dose of strawberries for four weeks in adults with obesity and above optimal blood
LDL-cholesterol [23]. We are now reporting serum biomarkers of antioxidants, endothelial
function, and inflammation in the same study population. We hypothesize that dietary supplementation of strawberries will improve these biomarkers in adults at risk for developing
T2D and related CVD pathologies.
2. Methods
2.1. Study Design and Criteria
As previously described, this was a randomized, crossover-controlled, double-blind
study for 14 weeks in which adult participants were recruited at three different campuses at
the University of Nevada at Las Vegas, University of Oklahoma Health Sciences Center, and
the Oklahoma State University [23]. The study was approved by the respective Institutional
Review Boards (IRB number 1119274) and was registered at http://clinicaltrials.gov/.
(Identifier: NCT03441620). All participants provided written informed consent. The study
criteria, as previously explained, involved inclusion based on above optimal serum LDLcholesterol and features of metabolic syndrome. Participants were excluded if they took
medications for lowering lipids and glucose levels, were allergic to strawberries, and/or
had chronic and acute health conditions that required medical treatment [23].
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2.2. Intervention and Protocol
Participants were randomized into one of three interventions for four weeks in the
crossover design with a one-week washout phase between each phase: control, one serving
of strawberries, or two-and-half servings of strawberries. The strawberries were administered as freeze-dried strawberry powder (FSP). The caloric content of the control and
strawberry powders ranged from 122 to 124 kcal, and the carbohydrate content ranged
from 27 to 29 g daily. While the control powder did not provide bioactive compounds, the
total polyphenols in one and two-and-half servings of FSP were 400 and 960 mg, respectively, and total anthocyanin content was 38 and 92 mg, respectively, as a daily dose. In
addition, fiber intake ranged from 3 to 5 g for the control and strawberry interventions [23].
The participants were instructed to reconstitute the powders in plain drinking water and
consume them as a beverage twice a day and at least six to eight hours apart. Health
history data and blood samples were collected at baseline and at the end of each four-week
phase of the study.
2.3. Biomarkers of Antioxidant Status
Serum samples collected at baseline and at the end of each four-week phase of the
study were analyzed for antioxidant biomarkers. Serum catalase and glutathione peroxidase (GPX) were determined using a spectrophotometric assay based on the manufacturer’s
protocol (Oxis Research, Portland, OR, USA). Glutathione reductase (GR) and superoxide
dismutase (SOD) activity were measured using commercially available kits (Cayman Chemical, Ann Arbor, MI, USA). Reduced glutathione was measured as previously described
by Beutler et al. [24] based on the absorbance of the yellow thiolate anion at 412 nm. Total
serum antioxidant capacity was measured using the metmyoglobin assay developed by
Miller et al. [25]. Serum nitrite was measured using the Griess Reagent System (Promega
Corporation, Madison, WI, USA). Serum malondialdehyde (MDA) levels were measured
by the method of Jain et al. [26] based on the reaction of MDA with thiobarbituric acid
to produce a complex that can be determined spectrophotometrically at 532 nm. All the
inter-assay CVs ranged between 3 and 7%.
2.4. Biomarkers of Endothelial Function and Inflammation
Serum adhesion molecules (soluble E-selectin [sE-Selectin], soluble P-selectin [sPSelectin], soluble intercellular adhesion molecule-1 [sICAM-1], and soluble vascular cell
adhesion molecule-1 [sVCAM-1]), as well as inflammatory analytes (interleukin [IL]-6,
IL-1β, tumor necrosis factor-α), were measured using a Quantikine human immunoassay
kits (R&D Systems, Minneapolis, MN, USA). All these inter-assay CVs ranged between 4
and 8%.
2.5. Statistical Analysis
Continuous variables are expressed as means ± SD and no value was detected as an
outlier. We used a mixed model ANOVA to examine the main effects of treatment, time,
and interactions, which were then used to analyze differences in outcomes at the end of
each four-week phase of intervention. Baseline values were included as covariates for
each outcome variable. Outcomes were modeled as repeated measures with the subject
as a random effect and with unstructured variance for treatment/time. The sequence
of intervention was included in all models to test for carry-over effects, and none were
detected. As an exploratory analysis, we also used correlation methods to examine positive
or inverse correlations among biomarkers of antioxidant status and inflammation. All
p values were 2-tailed and main effects and interaction effects were considered if <0.05.
Analyses were performed using SPSS, version 26.0 (SPSS, Armonk, NY, USA).
3. Results
As previously reported, a total of 33 adults (31 females, 2 males) completed all phases
of the randomized crossover study [23]. Enrolled participants had a baseline BMI of
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33 ± 3 kg/m2 (mean ± SD), 2 of the 33 were males who had a low intake of fruits and
vegetables at baseline (1.0 ± 0.4, and 1.3 ± 0.2 cups/day, respectively), and were insulin
resistant based on HOMA-IR (3.6 ± 1.5). Overall, BMI did not change after any phase of
the interventions in the study.
As shown in Table 1, among the biomarkers of antioxidant status, serum SOD and
antioxidant capacity significantly increased after the 4-week low dose as well as the high
dose, strawberry phase when compared to baseline and control phases. Serum MDA
significantly decreased after the 4-week low dose and high dose strawberry phases when
compared to the baseline and control phases. Serum levels of glutathione showed a
borderline significant increase following only the high dose strawberry phase.
Table 1. Serum antioxidants and oxidative stress biomarkers in adults with the metabolic syndrome following control, low,
and high-dose strawberry powder for a period of four weeks each in a randomized crossover study.
Variable

Baseline

Control
(4-Week)

Strawberry
(LD) (4-Week)

Strawberry
(HD) (4-Week)

p-Value 1
(Treatment)

Serum catalase, U/mL 2
Serum glutathione, µM
Serum GR, nmol/min/mL
Serum GPX, mU/mL
Serum SOD, U/mL
Serum nitrite, µM
Serum antioxidant capacity, µmol/L
Serum MDA, nmol/mL

55 ± 14
1021 ± 420
56 ± 14
22 ± 11
0.02 ± 0.01 a
32 ± 19
5.2 ± 4.3 a
5.16 ± 2.06 b

64 ± 11
997 ± 312
52 ± 16
25 ± 9
0.03 ± 0.02 a
26 ± 8
4.9 ± 4.2 a
4.86 ± 3.21 a

74 ± 17
1121 ± 332
62 ± 18
33 ± 8
0.04 ± 0.02 b
23 ± 11
6.5 ± 4.5 b
3.50 ± 2.06 b

67 ± 9
1143 ± 412
63 ± 12
29 ± 10
0.06 ± 0.04 b
25 ± 15
7.3 ± 3.5 b
3.21 ± 1.31 b

0.25
0.05
0.28
0.34
0.02
0.28
0.02
0.002

Data presented as means ± SD. N = 33/group. HD = High dose (~2.5 servings of strawberries/day); LD = low dose (~1.0 serving of
strawberries/day). GR = glutathione reductase; GPX = glutathione peroxidase; MDA = malondialdehyde; SOD = superoxide dismutase.
1 P for main effect of treatment from a mixed model ANOVA. Repeated measures adjusted for baseline values. a,b Different superscripts
indicate significantly different values. p < 0.05 in bold font. 2 P for significant time effect with higher values at 14 weeks compared to
baseline and four weeks (p < 0.05).

As shown in Table 2, among the biomarkers of endothelial dysfunction and inflammation, both serum sVCAM-1 and TNF-α were significantly decreased after the
4-week high dose strawberry phase when compared to baseline, control, and low dose
strawberry phases.
Table 2. Serum biomarkers of endothelial dysfunction and inflammation in adults with the metabolic syndrome following
control, low, and high-dose strawberries for a period of four weeks each in a randomized crossover study.
Variable

Baseline

Control
(4-Week)

Strawberry
(LD) (4-Week)

Strawberry
(HD) (4-Week)

p-Value 1
(Treatment)

Serum sICAM-1, ng/mL
Serum sVCAM-1, ng/mL
Serum sP-selectin, ng/mL
Serum sE-selectin, ng/mL
Serum IL-6, pg/mL
Serum IL-1β, pg/mL
Serum TNF-α, pg/mL

321 ± 109
288 ± 114 a
118 ± 65
37.4 ± 12.5
7.6 ± 4.4
12.7 ± 5.8
6.3 ± 3.5 a

333 ± 113
279 ± 103 a
124 ± 77
32.1 ± 10.5
6.8 ± 5.1
11.4 ± 6.4
5.7 ± 4.5 a

305 ± 95
262 ± 102 a
108 ± 75
28.6 ± 9.5
7.2 ± 6.4
10.7 ± 5.3
4.5 ± 3.2 a

311 ± 99
231 ± 98 b
111 ± 55
31.6 ± 11.5
6.3 ± 3.4
13.4 ± 6.5
3.8 ± 3.6 b

0.34
0.02
0.26
0.21
0.17
0.19
0.01

Data presented as means ± SD. N = 33/group. HD = High dose (~2.5 servings of strawberries/day); LD = low dose (~1.0 serving of
strawberries/day); IL-6 = interleukin-6; IL-1β = interleuin-1beta; sICAM-1 = soluble intercellular adhesion molecule-1; sVCAM-1 = soluble
vascular cell adhesion molecule-1; TNF-α = tumor necrosis factor alpha. 1 P for main effect of treatment from a mixed model ANOVA.
Repeated measures adjusted for baseline values. a,b Different superscripts indicate significantly different values. p < 0.05 in bold font.

Finally, in our exploratory analyses as shown in Table 3, we observed some significant
correlations among biomarkers in a model adjusted for baseline age and BMI. As expected,
we observed a significant inverse correlation between glutathione and antioxidant capacity
with sVCAM-1, and between SOD and TNF-α. In contrast, we observed a significant
positive correlation between serum MDA, a biomarker of lipid oxidation, and TNF-α, a
biomarker of inflammation.
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Table 3. Partial correlation coefficients among serum antioxidants, lipid oxidation, and inflammatory
biomarkers adjusted for age and BMI at baseline and at the end of the study.
Variable by Time

sICAM-1

sVCAM-1

IL-1β

TNF-α

Glutathione
Baseline
End

0.21
0.15

−0.42
−0.35

0.14
0.08

−0.12
−0.09

SOD
Baseline
End

−0.05
−0.06

−0.18
−0.23

−0.02
−0.02

−0.23
−0.19

Antioxidant capacity
Baseline
End

0.08
0.11

−0.25
−0.32

−0.05
−0.05

−0.03
−0.02

MDA
Baseline
End

0.07
0.05

0.13
0.15

0.03
0.02

0.28
0.35

N = 33 at baseline and end of study. Abbreviations: BMI = body mass index; MDA = malondialdehyde;
SOD = superoxide dismutase; IL−1β = interleuin-1beta; sICAM-1 = soluble intercellular adhesion molecule-1;
sVCAM-1 = soluble vascular cell adhesion molecule-1; TNF-α = tumor necrosis factor alpha. p < 0.05 in bold font.

4. Discussion
We observed some notable differences in antioxidant status and biomarkers of endothelial dysfunction and inflammation following a dietary intervention of two different
doses of strawberries in adults with cardiometabolic risk in a randomized crossover study.
There was a significant improvement in antioxidant status reflected by an increase in serum
SOD and overall antioxidant capacity, and a concomitant decrease in lipid peroxidation
following a four-week supplementation of one serving as well as two-and-a-half servings, of strawberries daily. Decreases were also observed in serum levels of the adhesion
molecule, sVCAM-1, and inflammatory biomarker, TNFα, following the same dose of
strawberries. To our knowledge, this is the first clinical study to identify improvements in
antioxidant status following a short-term supplementation of whole strawberries in adults
with habitual low consumption of fruits and vegetables, obesity, and insulin resistance.
Our findings of improved antioxidant status conform to the few reports on the role
of dietary berries conducted mostly in healthy adults. Strawberry supplementation has
been shown to increase plasma antioxidant capacity in healthy humans, though none of
these studies reported effects on antioxidant enzymes in the participants [27–29]. However,
a variety of other dietary bioactive rich compounds, such as curcumin and anthocyanins,
have also been shown to increase antioxidant enzymes in clinical trials. In adults with
metabolic syndrome, curcuminoid-piperine supplementation significantly increased serum
SOD activity as well as decreased serum MDA levels [30]. Similar results showed decreases
in MDA and serum SOD activity following red wine supplementation in healthy volunteers [31]. In a meta-analysis of 17 RCTs involving grape polyphenol supplementation,
significant increases in antioxidant capacity and SOD activity were observed in healthy
volunteers. Interestingly, no differences were noted in other antioxidant enzyme markers [32]. In another study of healthy humans, a 4-week supplementation of acai berry
juice significantly increased total blood antioxidant capacity, as well as catalase and GPX
activities [33]. Thus, while fruit-derived polyphenols may differentially affect each of the
antioxidant enzyme as biomarkers of improved health, there is a clear gap in the knowledge
of their effects in adults with cardiometabolic risks that our findings have addressed.
Our findings of decreased serum in the vascular adhesion molecule, VCAM-1, and
inflammatory molecule, TNF-α, following the higher dose supplementation of strawberries
in adults with cardiometabolic risks agree with our previously reported studies. These
include the effects of consuming approximately four-and-half servings of strawberries for
eight weeks that decreased serum VCAM-1 in adults with metabolic syndrome [34] and
the effects of a similar dose of strawberries that decreased serum TNF in adults with knee
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osteoarthritis and cardiometabolic risk [35]. The current findings have additional clinical
application as improvements were observed even at a lower dose of strawberry intake
than supplements in our earlier studies. This contrasts with the administration of wild
blueberry juice for seven days in adults at risk for T2D that showed no changes in glycemic
control and biomarkers of inflammation or adhesion molecules [36]. In preclinical models
of diet-induced atherosclerosis in mice, a combination of freeze-dried fruit and vegetable
powder decreased serum TNF-α at a dose of approximating eight to nine servings/day
in humans [37]. Similar decreases in inflammatory biomarkers, including interleukins
and TNFα, as well as adhesion molecules, were observed in endothelial cells treated with
Aronia berry extract [38]. Furthermore, Pietro et al. reported a comprehensive review
of dietary polyphenols by themselves or in combination with carotenoids, as found in
fruits and vegetables, to significantly reduce the expression of biomarkers of endothelial
dysfunction [39]. While these combined results provide some mechanistic insight into our
clinical observations, there remains an urgent need for further studies to document these
effects of dietary berries in adults with prediabetes and at risk for atherosclerotic CVD. In
this exploratory analysis, we observed significant inverse correlations of biomarkers of
antioxidant status with VCAM-1 and TNFα, as well as a positive correlation between lipid
peroxidation and TNFα in our pooled sample of all participants. Similar correlations have
been reported in observational studies in adults with metabolic syndrome or T2D [40–42],
thereby confirming the potential impact of antioxidant interventions derived from whole
foods on these populations at risk for CVD.
Some limitations of this study include it being a randomized crossover study and that
each phase lasted only four weeks. Longer duration studies should provide more robust
outcomes. We specifically included adults not taking medications for chronic conditions
such as T2D and CVD. Because of this, there are some limitations on the generalizability to
the larger population since a high number of people are medicated for these conditions.
Only MDA was explored as a biomarker of oxidative stress byproducts; future studies
should include effects on protein oxidation products and their associated effects on the
vasculature. Despite these limitations, we have reported novel data on the role of dietary
achievable strawberry bioactive agents in improving systemic antioxidant status and
inflammation in adults with cardiometabolic risks.
5. Conclusions
Our findings support that the dietary consumption of whole strawberries, fresh or
frozen, as a source of antioxidants, can perform as active nutritional therapy for CVD and
diabetes prevention and management. In addition to improving antioxidant status, strawberries also lowered the selected biomarkers of inflammation and endothelial dysfunction.
These data further strengthen the evidence of the cardioprotective role of strawberries in
adults with obesity and elevated cholesterol.
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